Skip to main content
Log in

Das Heerfordt-Syndrom — eine seltene Erstmanifestation der Sarkoidose

Heerfordt’s syndrome — a rare initial manifestation of sarcoidosis

  • Originalien
  • Published:
Mund-, Kiefer- und Gesichtschirurgie Aims and scope Submit manuscript

Zusammenfassung

Die Sarkoidose ist eine ätiologisch weitgehend unbekannte Systemerkrankung mit nicht verkäsenden epitheloidzelligen Granulomen. In der Genese werden infektiöse und genetische Komponenten diskutiert. Das Heerfordt-Syndrom mit Uveitis, Vergrößerung der Parotiden und fakultativer Fazialisparese stellt eine Ausprägungsform der Sarkoidose dar. Beweisend für die Diagnose der Sarkoidose ist die Histopathologie. In der Diagnostik werden noch eine Reihe weiterer Untersuchungen eingesetzt, wie z. B. die Fiberbronchoskopie mit bronchoalveolärer Lavage oder die Szintigraphie im Zusammenspiel mit laborchemischen Parametern. Kortikosteroide sind die in der medikamentösen Therapie am häufigsten eingesetzte Substanzgruppe. Wir beschreiben hier den Fall eines Heerfordt-Syndroms und geben einen ausführlichen Überblick über die unterschiedlichsten Aspekte der Sarkoidose.

Abstract

Sarcoidosis is a chronic, multisystem disorder of unknown cause characterized by noncaseating epithelioid granulomas. Infectious agents and genetic components have been discussed. Heerfordt’s syndrome with uveitis, enlargement of the parotid glands and optional paralysis of the Nn. facialis is a form of sarcoidosis. The diagnosis is confirmed by histology. Further analyses are fiberoptic bronchoscopy with bronchoalveolar lavage or the gallium-67 scan in combination with blood findings. The therapy of choice is glucocorticoids. We present a case report of Heerfordt’s syndrome and a review of the literature covering different aspects of sarcoidosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Altschuler EL (2003) The first case of sarcoidosis treated with mycophenolate mofetil. Br J Dermatol 149: 442–443

    Article  CAS  PubMed  Google Scholar 

  2. Baughman RP, Lynch JP (2003) Difficult treatment issues in sarcoidosis. J Intern Med 253: 41–45

    Article  CAS  PubMed  Google Scholar 

  3. Baughman RP, Ploysongsang Y, Roberts RD, Srivastava L (1983) Effects of sarcoid and steroids on angiotensin-converting enzyme. Am Rev Respir Dis 128: 631–633

    CAS  PubMed  Google Scholar 

  4. Baughman RP, Lower EE, Bois RM du (2003) Sarcoidosis. Lancet 361: 1111–1118

    Article  CAS  PubMed  Google Scholar 

  5. Belcher RW, Reid JD (1975) Sarcoid granulomas in CBA/J mice. Histologic response after inoculation with sarcoid and nonsarcoid tissue homogenates. Arch Pathol 99: 283–285

    CAS  PubMed  Google Scholar 

  6. Chailleux E, Bignon JD, Peyrat MA, Godard A, Soulillou JP (1985) Lymphocyte subsets, phytohaemagglutinin responsiveness of blood lymphocytes, and interleukin 2 production in sarcoidosis. Thorax 40: 768–773

    CAS  PubMed  Google Scholar 

  7. DeRemee RA, Rohrbach MS (1980) Serum angiotensin-converting enzyme activity in evaluating the clinical course of sarcoidosis. Ann Intern Med 92: 361–365

    CAS  PubMed  Google Scholar 

  8. Gazouli M, Ikonomopoulos J, Trigidou R, Foteinou M, Kittas C, Gorgoulis V (2002) Assessment of mycobacterial, propionibacterial, and human herpes virus 8 DNA in tissues of Greek patients with sarcoidosis, J Clin Microbiol 40: 3060–3063

    Google Scholar 

  9. Heyll A, Meckenstock G, Aul C et al. (1994) Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. Bone Marrow Transplant 14: 161–164

    CAS  PubMed  Google Scholar 

  10. Hosoya S, Kataoka M, Nakata Y et al. (1992) Clinical features of 125 patients with sarcoidosis: Okayama University Hospital review of a recent 10-year period. Acta Med Okayama 46: 31–36

    CAS  PubMed  Google Scholar 

  11. Iwai K, Takahashi S (1976) Transmissibility of sarcoid-specific granulomas in the footpads of mice. Ann N Y Acad Sci 278: 249–259

    CAS  PubMed  Google Scholar 

  12. Kouba DJ, Mimouni D, Rencic A, Nousari HC (2003) Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis. Br J Dermatol 148: 147–148

    Article  CAS  PubMed  Google Scholar 

  13. Lawrence EC, Teague RB, Gottlieb MS, Jhingran SG, Lieberman J (1983) Serial changes in markers of disease activity with corticosteroid treatment in sarcoidosis. Am J Med 74: 747–756

    Article  CAS  PubMed  Google Scholar 

  14. McGrath DS, Daniil Z, Foley P, Bois JL du, Lympany PA, Cullinan P, Bois RM du (2000) Epidemiology of familial sarcoidosis in the UK. Thorax 55: 751–754

    Article  CAS  PubMed  Google Scholar 

  15. Mitchell DN (1976) The nature and physical characteristics of a transmissible agent from human sarcoid tissue. Ann N Y Acad Sci 278: 233–248

    CAS  PubMed  Google Scholar 

  16. Power WJ, Neves RA, Rodriguez A, Pedroza-Seres M, Foster CS (1995) The value of combined serum angiotensin-converting enzyme and gallium scan in diagnosing ocular sarcoidosis. Ophthalmology 102: 2007–2011

    Google Scholar 

  17. Robinson BW, Rose AH, Thompson PJ, Hey A (1987) Comparison of bronchoalveolar lavage helper/suppressor T-cell ratios in sarcoidosis versus other interstitial lung diseases. Aust N Z J Med 17: 9–15

    CAS  PubMed  Google Scholar 

  18. Sharma OP (1996) Vitamin D, calcium, and sarcoidosis. Chest 109: 535–539

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Weibrich.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walter, C., Schwarting, A., Hansen, T. et al. Das Heerfordt-Syndrom — eine seltene Erstmanifestation der Sarkoidose. Mund Kiefer GesichtsChir 9, 43–47 (2005). https://doi.org/10.1007/s10006-004-0582-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10006-004-0582-4

Schlüsselwörter

Keywords

Navigation